ENDRA Life Sciences's total assets for Q4 2025 were $3.85M, an increase of 12.09% from the previous quarter. NDRA total liabilities were $1.59M for the fiscal quarter, a -3.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.